Not recruiting
Cystic fibrosis respiratory infection suppression
Not recruitingStudy of inhaled BX004 bacteriophage treatment for adults with cystic fibrosis who have chronic Pseudomonas aeruginosa lung infection
Investigational
Study of inhaled BX004 bacteriophage treatment for adults with cystic fibrosis who have chronic Pseudomonas aeruginosa lung infection
Investigational
- Disease:Cystic fibrosis respiratory infection suppression
- Substances:IHMA-2121771-1IHMA-2121771-2+1
Countries:
Czechia
Czechia- Participants:18–64 years · 65+ years
- Substances:IHMA-2121771-1
- Sponsor:Biomx Ltd.
